[Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease].
Niels TeichClara LudewigRenate SchmelzElke Christiane BästleinSven GeißlerSandra NaglJens WalldorfThomas KrauseChristian MaaserWolfgang MohlHeiner H WedemeyerTilman BauerCarsten BüningPhilip GrunertPeter HasselblattMarkus HänschenMatthias KahlOlaf EngelkeStefan SchubertBabett HollerKonrad StreetzUlrike von ArnimKaren SchmidtAndreas Stallmachnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullnull nullPublished in: Zeitschrift fur Gastroenterologie (2021)
New abdominal symptoms often appeared in SARS-CoV-2 infected IBD patients. However, these only rarely led to SARS-CoV-2 testing. A high IBD activity at the time of SARS-CoV-2 detection was associated with an increased risk of hospitalization.